Brokerages Set Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) PT at $27.50

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) has received an average rating of “Moderate Buy” from the six analysts that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $27.50.

A number of research analysts have recently commented on the stock. Stifel Nicolaus assumed coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued a “buy” rating and a $28.00 price target on the stock. Bank of America assumed coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued a “buy” rating and a $30.00 price target on the stock. Wolfe Research assumed coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an “outperform” rating and a $29.00 price target on the stock. Piper Sandler assumed coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an “overweight” rating and a $27.00 price target on the stock. Finally, The Goldman Sachs Group cut their price target on shares of Kestra Medical Technologies from $24.00 to $23.00 and set a “neutral” rating on the stock in a report on Wednesday, April 16th.

Hedge Funds Weigh In On Kestra Medical Technologies

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Yu Fan purchased a new position in shares of Kestra Medical Technologies in the 1st quarter valued at approximately $56,880,000. T. Rowe Price Investment Management Inc. purchased a new position in shares of Kestra Medical Technologies in the 1st quarter valued at approximately $56,613,000. Omega Fund Management LLC purchased a new position in shares of Kestra Medical Technologies in the 1st quarter valued at approximately $44,754,000. Alliancebernstein L.P. purchased a new position in shares of Kestra Medical Technologies in the 1st quarter valued at approximately $29,500,000. Finally, Brown Advisory Inc. purchased a new position in Kestra Medical Technologies during the 1st quarter worth approximately $13,716,000.

Kestra Medical Technologies Trading Up 2.9%

KMTS stock opened at $15.51 on Friday. Kestra Medical Technologies has a twelve month low of $14.15 and a twelve month high of $26.15. The company’s fifty day moving average price is $22.32.

Kestra Medical Technologies (NASDAQ:KMTS) last posted its quarterly earnings data on Monday, April 14th. The company reported ($1.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.64) by ($0.61). During the same quarter last year, the company posted ($1.18) EPS.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.